Prevalence of Hepatopathy in Type 1 Diabetic Children

Overview

Journal BMC Pediatr

Publisher Biomed Central

Specialty Pediatrics

Date 2012 Oct 9

PMID 23039762

Citations 17

Authors

Abdulrahman A Al-Hussaini

Nimer M Sulaiman

Musa D Alzahrani

Ahmed S Alenizi

Mannan Khan

Affiliations

Soon will be listed here.

Abstract

Background: The Prevalence of liver disease among diabetics has been estimated to be between 17% and 100%. Most of these data were obtained from adult studies. The aim of our study was to screen for liver disease among type 1 diabetic children.

Methods: Children with type 1 diabetes following in clinic have been examined for existence of liver disease, from November 2008 to November 2009. All were subjected to the following: History, physical examination, liver function tests, fasting lipid profile, HbA1C, and ultrasound of the liver. A hyperechogenic liver and/or hepatomegaly on ultrasound were attributed most likely to excess glycogen or fat in the liver, after negative extensive work-up to rule out other underlying liver disease.

Results: 106 children with type 1 diabetes were studied: age ranged between 8 months to 15.5 years, sixty two patients were females. Twenty two patients (21%) were identified to have abnormal findings on ultrasound of the liver: 10 patients had hepatomegaly and 12 had hyperechogenic liver. The group with hyperechogenic liver had poorer glycemic control than patients with normal liver (Mean HbA1c 12.14% Vs 10.7%; P value = 0.09). Hyperechogenic liver resolved in 60% at 6 months follow-up upon achieving better glycemic control.

Conclusions: Hyperechogenic liver and/or hepatomegaly are not uncommon in children with type 1 diabetes and tend to be more prevalent among children with poor glycemic control. Type 1 diabetes related hepatopathy is reversible by optimizing glycemic control. Because of its safety, and reliability, ultrasound can be used to screen for hepatopathy in type 1 diabetic child.

Citing Articles

Acute glycogenic hepatopathy in pregnancy: a case report and literature review.

Abuzeid O, Heiligenstein M, Noureddine L, Heiselman C, Bernasko J Case Rep Perinat Med. 2025; 11(1):20210065.

PMID: 40041230 PMC: 11800661. DOI: 10.1515/crpm-2021-0065.

Relationship between liver and cardiometabolic health in type 1 diabetes.

Tas E, Vu B, Mendizabal B, Libman I, Muzumdar R Front Endocrinol (Lausanne). 2024; 15:1505430.

PMID: 39605938 PMC: 11598439. DOI: 10.3389/fendo.2024.1505430.

Blood glucose control and metabolic dysfunction-associated steatotic liver disease in people with type 1 diabetes.

Della Pepa G, Lupoli R, Masulli M, Boccia R, De Angelis R, Gianfrancesco S J Endocrinol Invest. 2024; 47(9):2371-2378.

PMID: 38498227 PMC: 11368973. DOI: 10.1007/s40618-024-02333-2.

Phloretamide Prevent Hepatic and Pancreatic Damage in Diabetic Male Rats by Modulating Nrf2 and NF-κB.

Al-Hussan R, Albadr N, Alshammari G, Almasri S, Yahya M Nutrients. 2023; 15(6).

PMID: 36986192 PMC: 10059022. DOI: 10.3390/nu15061456.

Clinical and diagnostic characteristics of non-alcoholic fatty liver disease among Egyptian children and adolescents with type1 diabetes.

Abdallah H, Youness E, Bedeir M, Abouelnaga M, Ezzat W, Elhosary Y Diabetol Metab Syndr. 2023; 15(1):52.

PMID: 36941617 PMC: 10029237. DOI: 10.1186/s13098-023-01029-6.

References

Wasastjerna C, REISSELL P, Karjalainen J, Ekelund P . Fatty liver in diabetes. A cytological study. Acta Med Scand. 1972; 191(3):225-8. View

Stone B, Van Thiel D . Diabetes mellitus and the liver. Semin Liver Dis. 1985; 5(1):8-28. DOI: 10.1055/s-2008-1041754. View

Munns C, McCrossin R, Thomsett M, Batch J . Hepatic glycogenosis: reversible hepatomegaly in type 1 diabetes. J Paediatr Child Health. 2000; 36(5):449-52. DOI: 10.1046/j.1440-1754.2000.00547.x. View

Bacon B, Farahvash M, Janney C, Neuschwander-Tetri B . Nonalcoholic steatohepatitis: an expanded clinical entity. Gastroenterology. 1994; 107(4):1103-9. DOI: 10.1016/0016-5085(94)90235-6. View

Lorenz G, Barenwald G . Histologic and electron-microscopic liver changes in diabetic children. Acta Hepatogastroenterol (Stuttg). 1979; 26(6):435-8. View

Riley 3rd T, Mendoza A, Bruno M . Bedside ultrasound can predict nonalcoholic fatty liver disease in the hands of clinicians using a prototype image. Dig Dis Sci. 2006; 51(5):982-5. DOI: 10.1007/s10620-006-9343-6. View

Creutzfeldt W, Frerichs H, SICKINGER K . Liver diseases and diabetes mellitus. Prog Liver Dis. 1970; 3:371-407. View

Bardella M, Valenti L, Pagliari C, Peracchi M, Fare M, Fracanzani A . Searching for coeliac disease in patients with non-alcoholic fatty liver disease. Dig Liver Dis. 2004; 36(5):333-6. DOI: 10.1016/j.dld.2004.01.012. View

Falchuk K, Conlin D . The intestinal and liver complications of diabetes mellitus. Adv Intern Med. 1993; 38:269-86. View

10.

Nakamuta M, Ohashi M, Goto K, Tanabe Y, Hiroshige K, Nawata H . Diabetes mellitus-associated glycogen storage hepatomegaly: report of a case and review of the Japanese literature. Fukuoka Igaku Zasshi. 1993; 84(7):354-8. View

11.

Tak P, Ten Kate F . Remission of active diabetic hepatitis after correction of hyperglycemia. Liver. 1993; 13(4):183-7. DOI: 10.1111/j.1600-0676.1993.tb00628.x. View

12.

Targher G, Bertolini L, Padovani R, Rodella S, Zoppini G, Pichiri I . Prevalence of non-alcoholic fatty liver disease and its association with cardiovascular disease in patients with type 1 diabetes. J Hepatol. 2010; 53(4):713-8. DOI: 10.1016/j.jhep.2010.04.030. View

13.

Teli M, James O, Burt A, Bennett M, Day C . The natural history of nonalcoholic fatty liver: a follow-up study. Hepatology. 1995; 22(6):1714-9. View

14.

Goodman J . Hepatomegaly and diabetes mellitus. Ann Intern Med. 1953; 39(5):1077-87. DOI: 10.7326/0003-4819-39-5-1077. View

15.

Lecomte M, Gottrand F, Stuckens C, Lecomte-Houcke M . Acute steatosis in an 8-year-old boy with insulin-dependent diabetes mellitus. J Pediatr Gastroenterol Nutr. 1997; 25(1):98-100. DOI: 10.1097/00005176-199707000-00017. View

16.

Thompson E, Parks W, DRAKE R . Rapid alterations induced by insulin in hepatocyte ultrastructure and glycogen levels. Am J Anat. 1981; 160(4):449-60. DOI: 10.1002/aja.1001600408. View

17.

Carcione L, Lombardo F, Messina M, Rosano M, De Luca F . Liver glycogenosis as early manifestation in type 1 diabetes mellitus. Diabetes Nutr Metab. 2003; 16(3):182-4. View

18.

Konus O, Ozdemir A, Akkaya A, Erbas G, Celik H, Isik S . Normal liver, spleen, and kidney dimensions in neonates, infants, and children: evaluation with sonography. AJR Am J Roentgenol. 1998; 171(6):1693-8. DOI: 10.2214/ajr.171.6.9843315. View

19.

Silverman J, Pories W, Caro J . Liver pathology in diabetes mellitus and morbid obesity. Clinical, pathological, and biochemical considerations. Pathol Annu. 1989; 24 Pt 1:275-302. View

20.

El-Karaksy H, Anwar G, Esmat G, Mansour S, Sabry M, Helmy H . Prevalence of hepatic abnormalities in a cohort of Egyptian children with type 1 diabetes mellitus. Pediatr Diabetes. 2010; 11(7):462-70. DOI: 10.1111/j.1399-5448.2009.00627.x. View